The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments.


Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
07 2021
Historique:
received: 04 02 2020
accepted: 03 04 2021
pubmed: 28 4 2021
medline: 6 8 2021
entrez: 27 4 2021
Statut: ppublish

Résumé

Financial relationships between physicians and the pharmaceutical and medical device industries are common, but the factors associated with physicians receiving payments are unknown. The objective of this study is to evaluate the influence of physicians' professional networks' characteristics on the receipt of payments among physicians. Network analysis of cross-sectional data PARTICIPANTS: US physicians who shared Medicare patients with other physicians in 2015 (N=357,813). Proportion of a physician's professional network that received industry payments and other network characteristics including number of physician connections, how central the physician is within the network, and the tightness of the referral network in which a physician is located. Relative risk of receiving industry payments. We used modified Poisson regression to control for confounding by gender, time since graduation, practice size, and practice setting (teaching hospital vs. not). We included dummy variables for specialty and hospital referral region level. The proportion of a physician's peers in their professional network that received payments was strongly associated with receipt of pharmaceutical or device industry payments by the physician (top vs bottom quartile aRR=1.28, 95%CI=1.25-1.31). Physician's centrality within a network had a small positive effect on receiving payment (top vs bottom quartile aRR=1.02, 95%CI=1.01-1.04). Network density also had a small negative association with receipt of payment (top vs bottom quartile aRR=0.97, 95%CI=0.96-0.98). Network characteristics, particularly the receipt of payments among physicians one shares patients with, are associated with whether a physician receives payments. This finding has implications for institutional regulation of industry payments to physicians and demonstrates how institutional policy may impact not only the physicians within the institution but also physicians outside of the institution.

Sections du résumé

BACKGROUND
Financial relationships between physicians and the pharmaceutical and medical device industries are common, but the factors associated with physicians receiving payments are unknown.
OBJECTIVE
The objective of this study is to evaluate the influence of physicians' professional networks' characteristics on the receipt of payments among physicians.
DESIGN
Network analysis of cross-sectional data PARTICIPANTS: US physicians who shared Medicare patients with other physicians in 2015 (N=357,813).
EXPOSURE (INTERVENTION)
Proportion of a physician's professional network that received industry payments and other network characteristics including number of physician connections, how central the physician is within the network, and the tightness of the referral network in which a physician is located.
MAIN OUTCOME MEASURES
Relative risk of receiving industry payments. We used modified Poisson regression to control for confounding by gender, time since graduation, practice size, and practice setting (teaching hospital vs. not). We included dummy variables for specialty and hospital referral region level.
KEY RESULTS
The proportion of a physician's peers in their professional network that received payments was strongly associated with receipt of pharmaceutical or device industry payments by the physician (top vs bottom quartile aRR=1.28, 95%CI=1.25-1.31). Physician's centrality within a network had a small positive effect on receiving payment (top vs bottom quartile aRR=1.02, 95%CI=1.01-1.04). Network density also had a small negative association with receipt of payment (top vs bottom quartile aRR=0.97, 95%CI=0.96-0.98).
CONCLUSIONS
Network characteristics, particularly the receipt of payments among physicians one shares patients with, are associated with whether a physician receives payments. This finding has implications for institutional regulation of industry payments to physicians and demonstrates how institutional policy may impact not only the physicians within the institution but also physicians outside of the institution.

Identifiants

pubmed: 33904046
doi: 10.1007/s11606-021-06802-9
pii: 10.1007/s11606-021-06802-9
pmc: PMC8298740
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1858-1866

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001438
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2021. Society of General Internal Medicine.

Références

Appl Netw Sci. 2018;3(1):28
pubmed: 30839809
JAMA Intern Med. 2016 Aug 1;176(8):1114-1122
pubmed: 27322350
J Clin Oncol. 2015 Jan 1;33(1):100-6
pubmed: 25385736
JAMA. 2000 Jan 19;283(3):373-80
pubmed: 10647801
JAMA Intern Med. 2018 Mar 1;178(3):421-423
pubmed: 29255905
PLoS One. 2016 May 16;11(5):e0155474
pubmed: 27183221
JAMA. 2012 Jul 18;308(3):265-73
pubmed: 22797644
J Gen Intern Med. 2018 Oct;33(10):1604-1606
pubmed: 29948812
PLoS One. 2014 Oct 16;9(10):e110130
pubmed: 25330392
Health Serv Res. 2011 Oct;46(5):1592-609
pubmed: 21521213
PLoS One. 2018 Oct 1;13(10):e0204826
pubmed: 30273368
JAMA Intern Med. 2018 Jun 1;178(6):854-856
pubmed: 29630687
Oncologist. 2019 May;24(5):632-639
pubmed: 30728276
Science. 1973 Dec 14;182(4117):1102-8
pubmed: 4750608
Contemp Clin Trials. 2012 Sep;33(5):1019-22
pubmed: 22664644
BMJ Open. 2019 Sep 20;9(9):e031010
pubmed: 31542759
N Engl J Med. 2006 Nov 30;355(22):2330-7
pubmed: 17135586
PLoS Med. 2010 Oct 19;7(10):e1000352
pubmed: 20976098
Med Care. 2012 Feb;50(2):152-60
pubmed: 22249922
Med Care. 2015 Jun;53(6):534-41
pubmed: 25906013
J Health Econ. 2008 May;27(3):531-43
pubmed: 18192044

Auteurs

Aaron N Winn (AN)

Department of Clinical Sciences, Medical College of Wisconsin, School of Pharmacy, Milwaukee, WI, USA. awinn@mcw.edu.
Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA. awinn@mcw.edu.
Center for the Advancing Population Sciences, Medical College of Wisconsin, Milwaukee, WI, USA. awinn@mcw.edu.

Aaron P Mitchell (AP)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Nicole Fergestrom (N)

Center for the Advancing Population Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
Section of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Joan M Neuner (JM)

Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Center for the Advancing Population Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
Section of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

Justin G Trogdon (JG)

Gillings School of Global Public Health, Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH